Barcelona – 2nd October 2018 — Almirall, S.A. announced today that the Food and Drug Administration (FDA) has approved Seysara (sarecycline), a new, innovative first in class tetracycline-derived oral antibiotic for the treatment of inflammatory…Original Article
FDA Approves Seysara (sarecycline) for the Treatment of Moderate to Severe Acne
